Skip to main content

Month: April 2022

PRESS RELEASE:BIGBEN: FY 2021/22 SALES OF 275.7 M€, IN LINE WITH THE ANNOUNCED TARGET

                                                Press release            Lesquin, 25 April 2022 – 18:00 hrs FY 2021/22 SALES OF 275.7 M€, IN LINE WITH THE ANNOUNCED TARGET CONFIRMATION OF FY 2022/23 TARGETS BIGBEN INTERACTIVE (ISIN FR0000074072) today announced its annual sales for FY 2021/22 (period from 1st April to 31 March).IFRS – M€ 2021/222020/21ChangeSales1st half year (April – Sept.) 124.2 135.8 -8.5%       Nacon Gaming 73.0 86.6 -15.7%Bigben Audio / Telco 51.2 49.2 +4.1%3rdquarter (Oct. – Dec.) (1) 91.3 87.3 +4.5%       Nacon Gaming 51.2 48.6 +5.2%Bigben AudioVidéo / Telco 40.1 38.7 +3.5%4thquarter (Jan – March) (1) 60.3 69.7 -13.6%       Nacon Gaming 31.7 42.6 –25.6%Bigben AudioVidéo / Telco 28.6 27.2 +5.3%12 months (April – March) (1) 275.7 292.8 -5.8%       Nacon...

Continue reading

Karolinska Development’s portfolio company Promimic’s IPO offering fully subscribed

STOCKHOLM, Sweden, April 25, 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Promimic’s IPO offering was fully subscribed. Promimic is now provided with SEK 80 million before deductions for issue costs, profoundly strengthening the company’s position ahead of its continued growth journey. Trading in the company’s shares is estimated to begin on Friday, April 29 on Nasdaq First North Growth Market. The offering, which was aimed at both institutional investors and the general public in Sweden, was subscribed for 100 percent. The estimated first trading day on the Nasdaq First North Growth Market is April 29, 2022, where the shares will be traded under the short name “PRO”. “The full subscription of the listing issue testifies to Promimic’s strong position and growth strategy, which...

Continue reading

Generix Group announces the resumption of its listing as of April 26, 2022

FINANCIAL COMMUNICATION Paris, April 25, 2022 Generix Group announces the resumption of its listing as of April 26, 2022 Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions, announces the resumption of its listing as of Tuesday, April 26, 2022. The Group suspended its listing on Monday April 25, 2022 in the context of the announcement made on the evening of April 22, 2022 concerning the entry into exclusive negotiations between Generix, its management, Pléiade Investissement, and Montefiore Investment, with a view to concluding an investment protocol leading to the filing of a public takeover bid at a price of €9.50 per share, with an incentive of €0.50 per share if the 90% delisting threshold is reached. This suspension of the listing was intended to give all Generix Group shareholders...

Continue reading

LECTRA: Glengo Teknoloji joins forces with Lectra Turkey

Glengo Teknoloji joins forces with Lectra Turkey The two organizations will combine to develop Lectra’s business in the booming Turkish market Paris, April 25, 2022 – Lectra is pleased to announce Glengo Teknoloji (“Glengo”), the exclusive distributor of Gerber solutions in Turkey, will join forces with Lectra Turkey. Bringing Lectra Turkey and Glengo together provides an opportunity for both organizations to expand their footprint in Turkey, Central Asia and the Middle East, and better serve their customers. Lectra Turkey will become Glengo Lectra Teknoloji and distribute the entirety of the Lectra Group’s product portfolio. This union is the logical next step after Lectra’s acquisition of Gerber Technology (“Gerber”) in June 2021. Glengo was established in 1986. The Istanbul-based company has been providing sales, installation,...

Continue reading

Sydbank A/S releases its profit for Q1 2022 and revises upwards its expectations for profit for the year for 2022

        Company Announcement No 16/2022Peberlyk 46200 AabenraaDenmark Tel +45 70 10 78 79Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk25 April 2022  Dear Sirs Sydbank A/S releases its profit for Q1 2022 and revises upwards its expectations for profit for the year for 2022 As a result of a highly satisfactory start to 2022 with strong growth in bank loans and advances of DKK 4.6bn to DKK 71.6bn as well as a high level of activity, the expectation for profit for the year is revised upwards to be in the range of DKK 1,350-1,550m. In connection with the release of the 2021 Annual Report on 2 March 2022, we announced that we expected a profit after tax in the range of DKK 1,150-1,450m for 2022.   Income statementDKKmQ1 2022 Q12021 Index22/21 Full year2021Core income 1,200 1,105 109 4,436Trading...

Continue reading

BASF celebrates opening of new Center for Sustainable Agriculture

Center creates unique destination focused on sustainable agriculture’s impact on the environment, people, and planet RESEARCH TRIANGLE PARK, N.C., April 25, 2022 (GLOBE NEWSWIRE) — BASF opened its new Center for Sustainable Agriculture today with an official ribbon-cutting ceremony. The Center will provide visitors information and experiences covering a broad range of topics — from technology and innovation driving agriculture’s productivity to how healthy homes and communities are not much different than a farmer’s field. The ceremony featured information and tours for attendees, which included farmers, agriculture industry stakeholders, elected officials, community partners, members of the media, and BASF executives. Guests had an opportunity to engage with the Center’s interactive exhibits and tour the newly renovated gardens...

Continue reading

Wrap Technologies, Inc. Announces Release Date for First Quarter 2022 Results

TEMPE, Ariz., April 25, 2022 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (Nasdaq: WRAP) (the “Company”), a global leader in innovative public safety technologies and services, today announced that it will report first quarter fiscal 2022 results after the market closes on Tuesday, May 3, 2022. The Company will host an investor conference call at 4:30 pm ET on the same day to review its results. This call and all supplemental information can be accessed on Wrap’s investor relations website: https://wrap.com/investors/ The dial in information for the investor conference call:PARTICIPANT DIAL IN (TOLL FREE): 1-877-276-7742 PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-6582 WEBCAST LINK: Link to Wrap webcastA recording of the conference call will be available on the Company’s investor relations website. About WrapWrap Technologies...

Continue reading

Sorrento Announces FDA Authorization to Proceed with Phase 1 Study of Intravenous STI-9167 (COVISHIELD), a Potent Neutralization Antibody Against Omicron BA.2 and Other SARS-CoV-2 Variants of Concern

FDA granted IND clearance today for STI-9167 (Intravenous COVISHIELD™) for a Phase 1 safety and pharmacokinetic study in healthy volunteers. Initial trials are expected to be followed by a multinational Phase 2/3 trial in both mild and moderate COVID-19 patients. STI-9167 has demonstrated in vitro and in vivo activity against all SARS-CoV-2 variants tested, including the Omicron strain BA.1, Omicron BA.1.1 and Omicron BA.2.SAN DIEGO, April 25, 2022 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that it has received clearance from the FDA for its investigational new drug application (IND) for intravenous (IV) STI-9167 (COVISHIELD) to study the safety and pharmacokinetics in healthy volunteers. STI-9167 is the IV formulation of the intranasal STI-9199 neutralizing antibody. The...

Continue reading

Pervasip to Present at Emerging Growth Conference on April 27, 2022

SEATTLE, April 25, 2022 (GLOBE NEWSWIRE) — Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, today announced that it will present at the April 27, 2022 Emerging Growth Conference and invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation. Pervasip is pleased to announce that it has been invited to present at the Emerging Growth Conference on April 27, 2022. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO in real time. Mr. German Burtscher will perform a presentation and may subsequently open the floor for questions. Please ask your questions during the event and Mr. Burtscher...

Continue reading

Schouw & Co. share buy-back programme, week 16 2022

On 27 December 2022, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 10 of 21 December 2021. Under the programme, Schouw & Co. will acquire shares for up to DKK 350 million during the period 27 December 2021 to 30 December 2022. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount    Accumulated until 15/4/2022 248,321 561.28 139,376,873    Monday, 18 April 2022 – – –    Tuesday, 19 April 2022 0 – –    Wednesday, 20 April 2022 4,957 600.53 2,976,827    ...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.